Detection of breast cancer precursor lesions by autofluorescence ductoscopy.
Adult
BRCA1 Protein
/ genetics
BRCA2 Protein
/ genetics
Breast Neoplasms
/ diagnosis
Endoscopy
/ methods
Feasibility Studies
Female
Genetic Predisposition to Disease
Humans
Mammary Glands, Human
/ diagnostic imaging
Middle Aged
Mutation
Optical Imaging
/ methods
Precancerous Conditions
/ diagnosis
Prophylactic Mastectomy
/ methods
Prospective Studies
Young Adult
Breast cancer
Diagnosis
Ductoscopy
Journal
Breast cancer (Tokyo, Japan)
ISSN: 1880-4233
Titre abrégé: Breast Cancer
Pays: Japan
ID NLM: 100888201
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
03
02
2020
accepted:
16
07
2020
pubmed:
30
7
2020
medline:
22
6
2021
entrez:
30
7
2020
Statut:
ppublish
Résumé
Autofluorescence is an image enhancement technique used for the detection of cancer precursor lesions in pulmonary and gastrointestinal endoscopy. This study evaluated the feasibility of addition of autofluorescence to ductoscopy for the detection of intraductal breast cancer precursor lesions. An autofluorescence imaging system, producing real-time computed images combining fluorescence intensities, was coupled to a conventional white light ductoscopy system. Prior to surgery, ductoscopy with white light and autofluorescence was evaluated under general anaesthesia in women scheduled for therapeutic or prophylactic mastectomy. Endoscopic findings in both modes were compared, marked and correlated with histology of the surgical specimen. Four breast cancer patients and five high-risk women, with a median age of 47 years (range 23-62) were included. In autofluorescence mode, two intraductal lesions were seen in two breast cancer patients, which had an increase in the red-to-green fluorescence intensity compared with the surrounding tissue. One lesion had initially been missed by white light ductoscopy but was clearly visible in subsequent autofluorescence mode. One endoscopic finding was classified as suspicious by white light, but was negative in autofluorescence mode and showed normal histology. This study demonstrates for the first time the in vivo feasibility of autofluorescence ductoscopy to detect pathologically confirmed breast cancer precursor lesions in both breast cancer patients and high-risk women that were occult under white light.
Identifiants
pubmed: 32725533
doi: 10.1007/s12282-020-01136-6
pii: 10.1007/s12282-020-01136-6
pmc: PMC7796885
doi:
Substances chimiques
BRCA1 Protein
0
BRCA1 protein, human
0
BRCA2 Protein
0
BRCA2 protein, human
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
119-129Références
J Biomed Opt. 2009 Jul-Aug;14(4):044036
pubmed: 19725747
J Natl Cancer Inst. 1975 Aug;55(2):231-73
pubmed: 169369
Br J Surg. 2015 Dec;102(13):1639-48
pubmed: 26447629
Lasers Surg Med. 2018 Feb;50(2):137-142
pubmed: 28990682
BMC Cancer. 2006 Jun 23;6:164
pubmed: 16796740
Am J Surg. 2007 Dec;194(6):850-4; discussion 854-5
pubmed: 18005783
Breast J. 2009 Mar-Apr;15(2):168-75
pubmed: 19292803
Am J Surg. 2011 Feb;201(2):221-5
pubmed: 20870205
Surgery. 2002 Oct;132(4):582-7; discussion 587-8
pubmed: 12407341
Breast Cancer Res Treat. 2006 Oct;99(3):301-7
pubmed: 16752074
Onkologie. 2009 Mar;32(3):94-8
pubmed: 19295246
World J Gastroenterol. 2011 Oct 14;17(38):4271-6
pubmed: 22090782
Am J Surg. 2004 Mar;187(3):349-62
pubmed: 15006563
Am Surg. 2006 Feb;72(2):124-8
pubmed: 16536240
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6834-41
pubmed: 18006786
Anticancer Res. 2001 Nov-Dec;21(6A):4113-6
pubmed: 11911303
Breast Cancer. 2016 Mar;23(2):242-51
pubmed: 25150843
Clin Breast Cancer. 2020 Dec;20(6):e723-e748
pubmed: 32665191
Eur Respir J. 2005 Jun;25(6):951-5
pubmed: 15929947
Onkologie. 2006 Nov;29(11):501-6
pubmed: 17068384
Breast J. 2008 Sep-Oct;14(5):442-9
pubmed: 18673337
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):265-74
pubmed: 20056647
J Clin Oncol. 2000 May;18(9):1980-95
pubmed: 10784640
J Surg Oncol. 2006 Dec 1;94(7):555-64
pubmed: 17048242
Breast Cancer. 2014 Mar;21(2):154-61
pubmed: 22669683
Ann Surg. 2005 Apr;241(4):575-81
pubmed: 15798458
Breast Cancer Res Treat. 2009 Nov;118(1):9-13
pubmed: 18846422
JAMA Oncol. 2017 Sep 1;3(9):1190-1196
pubmed: 28418444
Ann Surg Oncol. 2011 Oct;18(11):3192-7
pubmed: 21847699
Am J Surg. 2016 Oct;212(4):660-669
pubmed: 27649974
Am J Surg. 2006 Oct;192(4):530-3
pubmed: 16978968
BMC Gastroenterol. 2012 Jun 22;12:75
pubmed: 22726319
Ann Oncol. 2011 Jan;22(1):24-29
pubmed: 20591821
Jpn J Clin Oncol. 1991 Jun;21(3):188-93
pubmed: 1658413
Breast Cancer. 2001;8(3):213-21
pubmed: 11668243
Breast J. 2004 Mar-Apr;10(2):111-7
pubmed: 15009037
Breast J. 2006 Sep-Oct;12(5 Suppl 2):S210-7
pubmed: 16959004
Breast Cancer Res Treat. 2001 Nov;70(2):103-8
pubmed: 11768599
Sci Transl Med. 2014 Jan 1;6(217):217ra2
pubmed: 24382894
Ann Surg Oncol. 2010 Mar;17(3):778-83
pubmed: 20012502
BMC Cancer. 2017 May 2;17(1):300
pubmed: 28464874
Oncotarget. 2017 Jun 15;8(37):60750-60763
pubmed: 28977823
J BUON. 2015 Mar-Apr;20(2):399-405
pubmed: 26011328
Diagn Ther Endosc. 1999;5(2):119-24
pubmed: 18493491
Ann Thorac Med. 2012 Jan;7(1):21-5
pubmed: 22347346
Clin Breast Cancer. 2007 Jun;7(8):619-23
pubmed: 17592674
Surg Endosc. 2011 Jun;25(6):1712-22
pubmed: 21170661
Onkologie. 2007 May;30(5):243-8
pubmed: 17460418
Lung Cancer. 2006 Apr;52(1):21-7
pubmed: 16497411
Respir Res. 2015 Mar 07;16:33
pubmed: 25848883
Clin Cancer Res. 2009 Jul 15;15(14):4700-5
pubmed: 19584169
Ann Surg Oncol. 2013 Oct;20(10):3212-7
pubmed: 23846780
Pathol Res Pract. 1980;166(4):515-35
pubmed: 6253967
Breast Cancer Res Treat. 2007 Dec;106(2):171-9
pubmed: 17221150
Minerva Chir. 2014 Apr;69(2):65-73
pubmed: 24847893
Clin Breast Cancer. 2020 Jun;20(3):e334-e343
pubmed: 32081573
Am J Hum Genet. 1998 Mar;62(3):676-89
pubmed: 9497246
J Clin Oncol. 2015 Nov 1;33(31):3660-7
pubmed: 26324357
J Minim Invasive Gynecol. 2005 Jul-Aug;12(4):359-64
pubmed: 16036199
Pathobiology. 2008;75(2):149-52
pubmed: 18544970
Breast. 2001 Apr;10(2):149-54
pubmed: 14965576
Cancer. 2015 Jan 1;121(1):25-33
pubmed: 25186627
J Comput Biol. 2006 Nov;13(9):1591-605
pubmed: 17147482
Ann Surg Oncol. 2013 Oct;20(10):3352-4
pubmed: 23975311
Int J Clin Oncol. 2005 Apr;10(2):112-6
pubmed: 15864696
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1243-51
pubmed: 19336560